About
Technology
Issues
FAQ
Search
Profile
Top Authors
Prolific Authors
Top Journals
Main Disciplines
Main Topics
Most Cited Articles
Scientometrics
Avg Impact Factor
★★
Articles
★★★
Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Schools
›
Department of Oncology
›
top-articles
Department of Oncology
158
(top 1%)
papers
8.8K
(top 1%)
citations
56
(top 1%)
h
-index
92
(top 1%)
g
-index
166
all documents
9.2K
doc citations
1.8K
citing journals
Top Articles
#
Title
Journal
Year
Citations
1
The emerging roles of forkhead box (Fox) proteins in cancer
Nature Reviews Cancer
2007
939
2
Definition of microRNAs That Repress Expression of the Tumor Suppressor Gene
FOXO1
in Endometrial Cancer
Cancer Research
2010
308
3
Thiostrepton selectively targets breast cancer cells through inhibition of forkhead box M1 expression
Molecular Cancer Therapeutics
2008
206
4
FOXO transcription factors: key regulators of cell fate
Biochemical Society Transactions
2006
198
5
Transcriptional Cross Talk between the Forkhead Transcription Factor Forkhead Box O1A and the Progesterone Receptor Coordinates Cell Cycle Regulation and Differentiation in Human Endometrial Stromal Cells
Molecular Endocrinology
2007
189
6
FOXM1 Confers Acquired Cisplatin Resistance in Breast Cancer Cells
Molecular Cancer Research
2010
172
7
Many forks in the path: cycling with FoxO
Oncogene
2008
165
8
A novel and validated prognostic index in hepatocellular carcinoma: The inflammation based index (IBI)
Journal of Hepatology
2012
164
9
Differential Expression of FOXO1 and FOXO3a Confers Resistance to Oxidative Cell Death upon Endometrial Decidualization
Molecular Endocrinology
2006
162
10
Brief Communication: Rituximab in HIV-Associated Multicentric Castleman Disease
Annals of Internal Medicine
2007
162
11
Induction of Mxi1-SRα by FOXO3a Contributes to Repression of Myc-Dependent Gene Expression
Molecular and Cellular Biology
2007
158
12
Positron emission tomography imaging of drug-induced tumor apoptosis with a caspase-3/7 specific [
18
F]-labeled isatin sulfonamide
Proceedings of the National Academy of Sciences of the United States of America
2009
157
13
The Forkhead Box M1 Protein Regulates the Transcription of the Estrogen Receptor α in Breast Cancer Cells
Journal of Biological Chemistry
2006
152
14
The Forkhead Transcription Factor FOXO3a Increases Phosphoinositide-3 Kinase/Akt Activity in Drug-Resistant Leukemic Cells through Induction of PIK3CA Expression
Molecular and Cellular Biology
2008
150
15
The Role of Androgen Receptor Mutations in Prostate Cancer Progression
Current Genomics
2009
147
16
The Androgen and Progesterone Receptors Regulate Distinct Gene Networks and Cellular Functions in Decidualizing Endometrium
Endocrinology
2008
140
17
Identification of 13 novel NLRP7 mutations in 20 families with recurrent hydatidiform mole; missense mutations cluster in the leucine-rich region
Journal of Medical Genetics
2009
138
18
Wnt-11 promotes neuroendocrine-like differentiation, survival and migration of prostate cancer cells
Molecular Cancer
2010
135
19
Expression of FOXA1 and GATA-3 in breast cancer: the prognostic significance in hormone receptor-negative tumours
Breast Cancer Research
2009
134
20
Estrogen Receptor β2 Negatively Regulates the Transactivation of Estrogen Receptor α in Human Breast Cancer Cells
Cancer Research
2007
133
21
A Small-Molecule Inhibitor for Phosphatase and Tensin Homologue Deleted on Chromosome 10 (PTEN)
ACS Chemical Biology
2006
131
22
Mechanism and functional consequences of loss of FOXO1 expression in endometrioid endometrial cancer cells
Oncogene
2008
130
23
Application of ProTide Technology to Gemcitabine: A Successful Approach to Overcome the Key Cancer Resistance Mechanisms Leads to a New Agent (NUC-1031) in Clinical Development
Journal of Medicinal Chemistry
2014
125
24
CpG island methylator phenotype (CIMP) in cancer: Causes and implications
Cancer Letters
2008
120
25
Mechano-transduction in Osteoblastic Cells Involves Strain-regulated Estrogen Receptor α-mediated Control of Insulin-like Growth Factor (IGF) I Receptor Sensitivity to Ambient IGF, Leading to Phosphatidylinositol 3-Kinase/AKT-dependent Wnt/LRP5 Receptor-independent Activation of β-Catenin Signaling
Journal of Biological Chemistry
2010
119
26
Gefitinib (Iressa) represses FOXM1 expression via FOXO3a in breast cancer
Molecular Cancer Therapeutics
2009
115
27
Regulation of prostate cell growth and morphogenesis by Dickkopf-3
Oncogene
2006
113
28
Phosphorylation at serines 104 and 106 by Erk1/2 MAPK is important for estrogen receptor-α activity
Journal of Molecular Endocrinology
2008
108
29
Regulation of the SUMO pathway sensitizes differentiating human endometrial stromal cells to progesterone
Proceedings of the National Academy of Sciences of the United States of America
2006
102
30
The DEAD-box protein p72 regulates ERα-/oestrogen-dependent transcription and cell growth, and is associated with improved survival in ERα-positive breast cancer
Oncogene
2009
102
31
CD3 limits the efficacy of TCR gene therapy in vivo
Blood
2011
101
32
The DEAD box RNA helicases p68 (Ddx5) and p72 (Ddx17): novel transcriptional co-regulators
Biochemical Society Transactions
2008
93
33
Phosphorylation of ERα at serine 118 in primary breast cancer and in tamoxifen-resistant tumours is indicative of a complex role for ERα phosphorylation in breast cancer progression
Endocrine-Related Cancer
2006
91
34
WWOX
Gene Expression Abolishes Ovarian Cancer Tumorigenicity
In vivo
and Decreases Attachment to Fibronectin via Integrin α3
Cancer Research
2009
91
35
FoxM1c Counteracts Oxidative Stress-induced Senescence and Stimulates Bmi-1 Expression
Journal of Biological Chemistry
2008
87
36
Resist or die: FOXO transcription factors determine the cellular response to chemotherapy
Cell Cycle
2008
81
37
Absence of Maternal Methylation in Biparental Hydatidiform Moles from Women with NLRP7 Maternal-Effect Mutations Reveals Widespread Placenta-Specific Imprinting
PLoS Genetics
2015
80
38
Phosphorylation of Estrogen Receptor-α at Ser167 Is Indicative of Longer Disease-Free and Overall Survival in Breast Cancer Patients
Clinical Cancer Research
2007
79
39
Inhibition of γ-secretase induces G2/M arrest and triggers apoptosis in breast cancer cells
British Journal of Cancer
2009
79
40
Comparison of bone marrow, disseminated tumour cells and blood-circulating tumour cells in breast cancer patients after primary treatment
British Journal of Cancer
2009
78
41
The transcription factor FOXO3a is a crucial cellular target of gefitinib (Iressa) in breast cancer cells
Molecular Cancer Therapeutics
2007
77
42
FoxM1 is a downstream target and marker of HER2 overexpression in breast cancer
International Journal of Oncology
2009
77
43
Monitoring Predominantly Cytostatic Treatment Response with
18
F-FDG PET
Journal of Nuclear Medicine
2009
75
44
Prohibitin, a protein downregulated by androgens, represses androgen receptor activity
Oncogene
2007
74
45
Detection of HER2 amplification in circulating free DNA in patients with breast cancer
British Journal of Cancer
2011
74
46
Mechanisms of androgen receptor activation in advanced prostate cancer: differential co-activator recruitment and gene expression
Oncogene
2008
73
47
Nicastrin regulates breast cancer stem cell properties and tumor growth in vitro and in vivo
Proceedings of the National Academy of Sciences of the United States of America
2012
71
48
The liver receptor homolog-1 regulates estrogen receptor expression in breast cancer cells
Breast Cancer Research and Treatment
2011
70
49
The clinical significance of disseminated tumor cells in breast cancer
Nature Clinical Practice Oncology
2007
68
50
Measurements of EGFR expression on circulating tumor cells are reproducible over time in metastatic breast cancer patients
Pharmacogenomics
2009
67
site/software ©
exaly
; All materials licenced under
CC by-SA
.